HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mie Shimizu Selected Research

Complement C5 (Complement 5)

1/2017Complement component 5 promotes lethal thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mie Shimizu Research Topics

Disease

6Acute Lung Injury
11/2009 - 08/2003
5Ischemic Stroke
01/2017 - 07/2011
4Cerebral Infarction
06/2013 - 04/2003
3Stroke (Strokes)
03/2021 - 01/2017
2Atrial Fibrillation
01/2021 - 01/2020
2Neoplasms (Cancer)
11/2018 - 08/2015
2Lung Injury
08/2007 - 08/2003
2Edema (Dropsy)
08/2007 - 06/2005
1Transient Ischemic Attack
03/2021
1Inflammation (Inflammations)
11/2018
1Brain Injuries (Brain Injury)
04/2017
1Diabetes Mellitus
04/2017
1Type 2 Diabetes Mellitus (MODY)
04/2017
1Thrombosis (Thrombus)
01/2017
1Hemorrhagic Stroke
12/2015
1Tremor (Tremors)
01/2009
1Pneumonia (Pneumonitis)
01/2008
1Pulmonary Edema
08/2007
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2006
1Hypertension (High Blood Pressure)
11/2006
1Transient Global Amnesia
08/2004
1Infections
08/2003
1Obstructive Sleep Apnea
12/2002
1Liver Cirrhosis (Hepatic Cirrhosis)
12/2002

Drug/Important Bio-Agent (IBA)

5EndotoxinsIBA
11/2009 - 08/2003
4LipopolysaccharidesIBA
01/2008 - 08/2003
2Clopidogrel (Plavix)FDA Link
03/2021 - 12/2015
2DabigatranFDA Link
01/2021 - 01/2020
2Cilostazol (Pletal)FDA LinkGeneric
04/2017 - 01/2017
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
12/2015 - 07/2011
2Ticlopidine (Ticlid)FDA LinkGeneric
01/2009 - 04/2003
2Escherichia coli endotoxinIBA
01/2008 - 06/2005
2Monoclonal AntibodiesIBA
08/2007 - 08/2003
1Adenosine Diphosphate (ADP)IBA
03/2021
1Purinergic P2Y Receptor AntagonistsIBA
03/2021
1AntithrombinsIBA
01/2021
1Indicators and Reagents (Reagents)IBA
11/2018
1Prealbumin (Transthyretin)IBA
11/2018
1Type 3 Cyclic Nucleotide PhosphodiesterasesIBA
04/2017
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2017
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2017
1Complement C5 (Complement 5)IBA
01/2017
1Histones (Histone)IBA
01/2017
1Atorvastatin (Lipitor)FDA Link
12/2015
1Epoprostenol ReceptorsIBA
06/2013
1EnzymesIBA
11/2009
1Y 41654IBA
11/2009
1ADAM17 ProteinIBA
11/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2009
1Toll-Like Receptor 4IBA
01/2008
1AlbuminsIBA
08/2007
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2007
1Peroxidase (Myeloperoxidase)IBA
06/2005
1Serum AlbuminIBA
06/2005
1rho-Associated KinasesIBA
06/2005
1Y 27632IBA
06/2005
1Fibrinogen ReceptorsIBA
08/2004
1AntibodiesIBA
08/2004
1P-SelectinIBA
08/2004
1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2003
1Cell Surface ReceptorsIBA
08/2003
1CytokinesIBA
08/2003
1NF-kappa B (NF-kB)IBA
08/2003
1Collagen Type III (Type III Collagen)IBA
12/2002
1procollagen Type III-N-terminal peptide (PIIP)IBA
12/2002

Therapy/Procedure

4Therapeutics
11/2018 - 12/2002
2Palliative Care (Palliative Therapy)
11/2018 - 08/2015
1Secondary Prevention
12/2015
1Drug Therapy (Chemotherapy)
08/2015
1Kampo Medicine (Kampo)
11/2006
1Intravenous Injections
06/2005
1Continuous Positive Airway Pressure
12/2002